Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study

✍ Scribed by Gini F. Fleming; Michael W. Sill; Kathleen M. Darcy; D. Scott McMeekin; J. Tate Thigpen; Lisa M. Adler; Jonathan S. Berek; Julia A. Chapman; Paul A. DiSilvestro; Ira R. Horowitz; James V. Fiorica

• Book ID: 113962231
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 477 KB
• Volume: 116
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2009.09.025